SGLT2 inhibitor therapy is associated with a lower risk for iron deficiency anaemia than DPP-4 inhibitor therapy in patients with T2D, a real-world study shows.
Medscape News UK
Source link : https://www.medscape.com/viewarticle/sglt2-inhibitors-may-protect-against-anaemia-t2d-2025a1000md3?src=rss
Author :
Publish date : 2025-08-28 12:00:00
Copyright for syndicated content belongs to the linked Source.
